“…The key step in in vitro diagnosis assays is to capture or detect these biomarkers, which is essential for the subsequent analysis of tumor diagnosis, metastasis, and prognosis (P. Ding, Wang, Wu, Zhou, et al, 2020; P. Ding, Wang, Wu, Zhu, et al, 2020; H. Liu, Sun, et al, 2020). Common detection methods include quartz crystal microbalance (QCM) (B. Li et al, 2020), electrochemiluminescence (ECL) (Babamiri, Hallaj, & Salimi, 2018; Shi, Li, & Hu, 2019), electrochemical impedance spectroscopy (EIS) (Cevik, 2019), flow cytometry (Doan et al, 2018), fluorescence (W. Zhou, Wang, et al, 2020), and others. A previous review has comprehensively covered the application of nanotechnology in CTCs detection (Myung, Park, Wang, & Hong, 2018).…”